RiboX focuses on the discovery and development of fully engineered circular RNA therapeutics - a new class of RNA medicines which can overcome current limitations of mRNA therapeutics and realize the full potential of RNA medicines.
Chief Executive Officer
Head of IP & Corporate Legal
Head of Development Sciences
Head of Molecular Engineering
Head of CMC
Head of Research
Head of Site (Israel)
Head of Business Development
Head of Business Operations